PSMD10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.666600E-01
Normal-vs-Stage2
8.219800E-01
Normal-vs-Stage3
3.990600E-01
Normal-vs-Stage4
5.562200E-01
Stage1-vs-Stage2
5.873200E-01
Stage1-vs-Stage3
1.127240E-01
Stage1-vs-Stage4
9.252600E-01
Stage2-vs-Stage3
1.990400E-01
Stage2-vs-Stage4
5.864000E-01
Stage3-vs-Stage4
2.097400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.715000E-01
Normal-vs-AfricanAmerican
6.467600E-01
Normal-vs-Asian
7.952800E-01
Caucasian-vs-AfricanAmerican
9.152400E-01
Caucasian-vs-Asian
2.936200E-01
AfricanAmerican-vs-Asian
4.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.415800E-01
Normal-vs-Female
7.001800E-01
Male-vs-Female
5.186200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.212800E-01
Normal-vs-Age(41-60Yrs)
3.132000E-01
Normal-vs-Age(61-80Yrs)
9.553000E-01
Normal-vs-Age(81-100Yrs)
7.670400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.395200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.650200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.029200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.354300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.125900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.874600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.898000E-01
Normal-vs-Daily Drinker
9.422400E-01
Normal-vs-Weekly Drinker
7.527200E-01
Normal-vs-Occasional Drinker
2.988000E-01
Normal-vs-Social Drinker
5.964200E-01
Non Drinker-vs-Daily Drinker
4.908800E-01
Non Drinker-vs-Weekly Drinker
9.035800E-01
Non Drinker-vs-Occasional Drinker
4.778100E-03
Non Drinker-vs-Social Drinker
1.181570E-01
Daily Drinker-vs-Weekly Drinker
5.133200E-01
Daily Drinker-vs-Occasional Drinker
4.697900E-02
Daily Drinker-vs-Social Drinker
4.039200E-01
Weekly Drinker-vs-Occasional Drinker
2.106100E-02
Weekly Drinker-vs-Social Drinker
1.694150E-01
Occasional Drinker-vs-Social Drinker
2.813200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.670800E-01
Normal-vs-Grade 2
7.228200E-01
Normal-vs-Grade 3
6.826200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.373200E-01
Grade 1-vs-Grade 3
8.280200E-01
Grade 1-vs-Grade 4
3.670800E-01
Grade 2-vs-Grade 3
3.301000E-01
Grade 2-vs-Grade 4
7.228200E-01
Grade 3-vs-Grade 4
6.826200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.859800E-01
Normal-vs-NonDiabetic
7.602400E-01
Diabetic-vs-NonDiabetic
8.598300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.503400E-01
Normal-vs-NoPancreatitis
8.657800E-01
Pancreatitis-vs-NoPancreatitis
6.797600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.697400E-01
Normal-vs-N1
7.962000E-01
N0-vs-N1
8.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.076600E-01
Normal-vs-TP53-NonMutant
8.614200E-01
TP53-Mutant-vs-TP53-NonMutant
4.759600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
